ArticleBiosensors2026
Pigment-Resistant, Portable Corneal Fluorescence Device for Non-Invasive AGEs Monitoring in Diabetes.
Article in Biosensors, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
Abstract
Advanced glycation end products (AGEs) are important biomarkers associated with diabetes and metabolic disorders; yet existing detection methods are invasive and unsuitable for frequent monitoring. This study aimed to develop a non-invasive and portable AGEs detection device, optimize strategies for mitigating pigmentation-related interference, and evaluate its feasibility for metabolic assessment. The proposed system employs a 365 nm ultraviolet LED excitation source, an optical filter assembly integrated into an ergonomic dark chamber, and an eyelid-signal-based algorithm to suppress ambient light and skin pigmentation interference. Simulation experiments were conducted to evaluate the influence of different pigment colors and skin tones on fluorescence measurements. A clinical study was performed in 200 participants, among whom 42 underwent concurrent serum AGEs measurement as the reference standard. Predictive models combining corneal fluorescence signals and body mass index (BMI) were constructed and evaluated. The results indicated that purple and blue pigments introduced greater interference, whereas green and pink pigments had minimal effects. Device-derived AGEs estimates demonstrated good agreement with serum AGEs, with a mean error below 8%. A hybrid model incorporating BMI achieved improved predictive accuracy compared with single-parameter models. Participants with high-AGE dietary habits exhibited elevated fluorescence signals and BMI. These findings suggest that the proposed device enables stable and accurate non-invasive AGEs assessment, with potential utility for metabolic monitoring. Incorporating lifestyle-related parameters may further enhance predictive performance and expand clinical applicability.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.